You have learned that a service level agreement functions as a contract defining service standards. The
telecommunications company provides the cloud service provider (CSP) to its customer and options for recourse should
those service levels not be met.
Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP) are the three top contenders for cloud
platform market share. Please select one of these CSPs and research the service level agreement (SLA) material available
on their site.
Prepare a report.
- Describe the process to locate SLA information for your selected platform,
- Discuss how much detail is provided for potential or existing customers.
- Summarize the available SLA content to include determining appropriate IP address spaces in cloud networks and
segmentation configurations for network and compute services.
ups in GCS, APACHEll, and SOFA scores. At the end of the study, a significant difference was observed in GCS and APACHEll scores in two groups (p = 0.028 and p = 0.049, respectively). Although mortality rate and ventilator dependency duration in the taurine group were less than the control group, this difference was not significant (p = 0.240 and p = 0.215, respectively). Also, no difference was observed between the groups in length of ICU stay (p = 0.963). The present study was a double-blind randomized clinical trial to determine the effect of taurine on patients with traumatic brain injury fed through enteral route. Generally, patients who received taurine showed better clinical outcomes compared with the patients who did not receive taurine. About the safety of the of taurine used in the present study, it is reported that 3-6 g/day taurine for one year does not have any harmful effects on the health (31) and about the effectiveness, Elmokadem et al. (29) suggested that in critically ill septic patients, 30 mg/kg/day taurine reduces IL-6 (as an important marker of immune and inflammatory response in the central nervous system). Therefore, based on the evidence, we decided to administer 30 mg/kg/day with the maximum dose of 3 g/day of taurine. To our best knowledge, this is the first clinical trial that has investigated the effect of taurine on patients with traumatic brain injury. Taurine has anti-inflammatory effects that can explain the beneficial effects of this amino acid in traumatic brain injury. One of the recommended protective mechanisms for taurine, is it’s reaction with hypochlorous acid to produce taurine chloramine (Tau-Cl) that is a strong anti-inflammatory factor. Hypochlorous acid is a reactive molecule in neutrophils and monocytes of mammalians that is produced through myeloperoxidase pathway (32, 33). Taurine chloramine negatively regulates the production of inflammatory proteins such as TNF-a and IL-6 by phagocytic cells. This process suppresses the inflammatory reaction and protects cells against cytotoxic and cytolytic activity of hypochlorous acid (34). IL-6 is an important inflammatory and immune response marker in central nervous system that was assessed in this trial. Early studies have shown that in patients with traumatic brain injury, IL-6 levels in CSF are significantly higher than plasma levels (35). In previous studies, taurine has significantly reduced IL-6 levels (29, 36-40). Similarly, the present study showed that taurine suppresses the elevated levels of IL-6 due to traumatic br>GET ANSWER